Raphael Pharmaceutical (RAPH) Total Debt Growth (3y) (2024 - 2025)

Raphael Pharmaceutical (RAPH) Total Debt Growth (3y) (2024 - 2025) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt Growth (3y) (Qtr)
1	Haleon	43.94 Bn	42.97 Bn	-	15.43%
2	Teva Pharmaceutical Industries	43.08 Bn	39.43 Bn	2.15 Bn	-7.08%
3	Zoetis	31.54 Bn	29.87 Bn	1.05 Bn	11.33%
4	Takeda Pharmaceutical	28.60 Bn	22.80 Bn	5.10 Bn	-3.67%
5	United Therapeutics	22.12 Bn	19.46 Bn	683.80 Mn	-
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	-10.43%
7	Neurocrine Biosciences	15.50 Bn	15.11 Bn	935.80 Mn	-
8	Elanco Animal Health	11.69 Bn	11.16 Bn	798.00 Mn	-13.72%
9	Dr Reddys Laboratories	10.13 Bn	9.96 Bn	-	92.83%
10	Raphael Pharmaceutical	28.25 Mn	28.25 Mn	-	-

Download Data